Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Ibogaine

Recent news which mentions Ibogaine

Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
Tickers ATAI DMT MDMA NEWS
Tags MDMA Srinivas Rao DMT
From Benzinga
DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling
Tickers NEWS
Tags Psilocybin Ibogaine Psychedelics
From Benzinga
Clearmind Medicine Files International Patent For Ibogaine Combination Therapy
Tickers CMND NEWS SPRC
Tags SPRC Benzinga Market News
From Benzinga
Google Co-Founder Sergey Brin Pledges $15M To Psychedelics Research Start-Up
Tickers GOOG NEWS TSLA
Tags GOOG News Soneira
From Benzinga
At 77, Cannabis Champion Dana Beal Fights Idaho Laws To Push Legalization In Hostile Territory
Tickers NEWS
Tags Market News Adam Eidinger Don Wirtshafter
From Benzinga
Cannabis Crusader Dana Beal's Incarceration: A Blow To Legalization Advocacy And Psychedelic Policy Reform
Tags Cannabis Market News Politics
From Benzinga
Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More
Tickers AMA ATAI CMND CMPS
Tags GHRS Penny Stocks Benzinga
From Benzinga
This Maine City Moves Unanimously On Decriminalizing Psychedelics: Focus On Public Health
Tags Ibogaine Wendy Chapkis Maine Psychedelics
From Benzinga
Psychedelics To Treat Addiction? How Substances Like Ibogaine Are Changing The Game
Tags Psychedelics General therapy
From Benzinga
African Iboga Root Heads To Canadian Company Developing Natural Drugs To Help Treat Addictions
Tickers FLHLF
Tags Nagoya Protocol Psychedelics Ibogaine
From Benzinga
EXCLUSIVE: Ibogaine Therapy Co. Bienstar On Successful Addiction Treatment, Global Market & Future Prospects
Tags Interview News Bienstar Wellness Corp
From Benzinga
Psychedelics Update: MDMA Export, 3D Farm, Recovery Center Reopens, Mushroom Extraction & E-Commerce
Tickers PSYCF PSYGF TRUFF
Tags Ibogaine Psychedelics Health Canada Approval
From Benzinga
Ibogaine To Treat Addiction: 5 Reasons Why It's Safer To Do It In Hospital Settings
Tags Ibogaine Psychedelics Health Care
From Benzinga
Science Feature: Next-Generation Psychedelics
Tickers DMT
Tags contributors Benzinga Market News
From Benzinga
MindMed Reports Promising Results For Non-Hallucinogenic Ibogaine Congener Substance
Tickers MNMD
Tags Markets MindMed News
From Benzinga
Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!
Tickers ATAI AWKNF CYBN ENVB
Tags AWKNF Psychedelics Ibogaine
From Benzinga
What Is Iboga And How Does It Compare To Cannabis, Exactly?
Tags Benzinga contributors Markets
From Benzinga
5 Psychedelics For Mental Health
Tags Benzinga contributors Cannabis
From Benzinga
Are Psychedelics Starting to Emerge as Legitimate Therapies?
Tickers DMT MDMA
Tags Doc Gumshoe AdvisorShares Psychedelics ETF (PSIL) Atai Life Sciences
From Stock Gumshoe
MindMed Successfully Completes Phase 1 Trial Of 18-MC
Tickers MNMD
Tags psychedelics MNMD clinical trial
From Benzinga
National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000
Tickers ATAI NVMDF
Tags Markets NVMDF Regulations
From Benzinga
Novamind Partners With Bienstar Wellness, Opening Door To Ibogaine Treatment For Addiction Disorders
Tickers MAPS NVMDF
Tags Cannabis Market News Benzinga
From Benzinga
New Study Links Psychedelic Use With 55 Percent Decrease In Daily Opioid Use
Tags Cannabis Market News Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.